Matches in SemOpenAlex for { <https://semopenalex.org/work/W3205200332> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W3205200332 abstract "Abstract Background Prostaglandin E2 receptor 4 (EP4) plays a crucial role in inflammatory diseases. Inflammatory cardiomyopathy often leads to refractory heart failure. Purpose We aimed to evaluate the role of EP4 in the development of inflammatory cardiomyopathy. Methods Experimental autoimmune myocarditis (EAM) was induced by immunization with cardiac myosin in balb/c mice. EP4 selective antagonist (CJ-42794, Cayman Chemical: 30 mg/kg/day), EP4 selective agonist (20 mg/kg/day), both, or vehicle alone was daily administrated after the immunization. Cardiac function and dimensions were assessed by echocardiography. Blood pressure and heart rate were assessed with tail-cuff method. Cardiac inflammation and fibrosis were immunohistologically examined. Molecular examination was performed by RT-PCR and immunoblotting. Results Cardiac dysfunction and dilatation were worsened on day 21 in EP4 antagonist-treated group compared with in the vehicle-treated group, accompanied by an increase in cellular infiltration area (21.7±1.9 vs. 11.0±2.7%, P=0.0367, respectively). Conversely, cardiac dysfunction and dilatation were improved in EP4 agonist-treated group compared with in the vehicle-treated group (Left ventricular fractional shortening: 69±3% vs. 40±4%, P<0.0001; Left ventricular systolic dimension: 0.7±0.1mm vs. 1.9±0.3mm, P=0.0007; respectively). These parameters did not show significant differences between both-treated group and the vehicle-treated group. The protective effect of EP4 stimulation in EAM was also kept on day 56. Moreover, cardiac fibrosis area as well as mRNA expressions of Type III collagen and brain natriuretic peptide in the bulk hearts was significantly reduced on day 56 in EP4 agonist-treated group compared with in the vehicle-treated group (12.3±2.4% vs. 24.7±3.0%, P=0.0278, respectively). Cardiac expression of phosphorylated smad 2/3 protein as well as TGF-β1 mRNA did not show significant differences between the 2 groups, while cardiac expression of RORgammat protein, the master regulator of Th17 immunity was increased in the EP4 antagonist-treated group. Conclusions EP4 activation negatively regulated the induction of cardiac autoimmunity, which alleviated cardiac dysfunction, dilatation, and fibrosis. EP4 may be a therapeutic target for preventing the development of inflammatory cardiomyopathy. FUNDunding Acknowledgement Type of funding sources: None." @default.
- W3205200332 created "2021-10-25" @default.
- W3205200332 creator A5011761462 @default.
- W3205200332 creator A5043718414 @default.
- W3205200332 creator A5061119813 @default.
- W3205200332 creator A5065752041 @default.
- W3205200332 creator A5066812049 @default.
- W3205200332 creator A5069506219 @default.
- W3205200332 creator A5086658242 @default.
- W3205200332 date "2021-10-01" @default.
- W3205200332 modified "2023-09-24" @default.
- W3205200332 title "Therapeutic role of Prostaglandin E2 receptor 4 stimulation in inflammatory cardiomyopathy" @default.
- W3205200332 doi "https://doi.org/10.1093/eurheartj/ehab724.0905" @default.
- W3205200332 hasPublicationYear "2021" @default.
- W3205200332 type Work @default.
- W3205200332 sameAs 3205200332 @default.
- W3205200332 citedByCount "0" @default.
- W3205200332 crossrefType "journal-article" @default.
- W3205200332 hasAuthorship W3205200332A5011761462 @default.
- W3205200332 hasAuthorship W3205200332A5043718414 @default.
- W3205200332 hasAuthorship W3205200332A5061119813 @default.
- W3205200332 hasAuthorship W3205200332A5065752041 @default.
- W3205200332 hasAuthorship W3205200332A5066812049 @default.
- W3205200332 hasAuthorship W3205200332A5069506219 @default.
- W3205200332 hasAuthorship W3205200332A5086658242 @default.
- W3205200332 hasConcept C111566952 @default.
- W3205200332 hasConcept C126322002 @default.
- W3205200332 hasConcept C134018914 @default.
- W3205200332 hasConcept C164705383 @default.
- W3205200332 hasConcept C170493617 @default.
- W3205200332 hasConcept C24998067 @default.
- W3205200332 hasConcept C2775915353 @default.
- W3205200332 hasConcept C2776885963 @default.
- W3205200332 hasConcept C2776914184 @default.
- W3205200332 hasConcept C2777420927 @default.
- W3205200332 hasConcept C2777953023 @default.
- W3205200332 hasConcept C2778198053 @default.
- W3205200332 hasConcept C2778797674 @default.
- W3205200332 hasConcept C2778938600 @default.
- W3205200332 hasConcept C2780559512 @default.
- W3205200332 hasConcept C2780875844 @default.
- W3205200332 hasConcept C71924100 @default.
- W3205200332 hasConcept C84393581 @default.
- W3205200332 hasConceptScore W3205200332C111566952 @default.
- W3205200332 hasConceptScore W3205200332C126322002 @default.
- W3205200332 hasConceptScore W3205200332C134018914 @default.
- W3205200332 hasConceptScore W3205200332C164705383 @default.
- W3205200332 hasConceptScore W3205200332C170493617 @default.
- W3205200332 hasConceptScore W3205200332C24998067 @default.
- W3205200332 hasConceptScore W3205200332C2775915353 @default.
- W3205200332 hasConceptScore W3205200332C2776885963 @default.
- W3205200332 hasConceptScore W3205200332C2776914184 @default.
- W3205200332 hasConceptScore W3205200332C2777420927 @default.
- W3205200332 hasConceptScore W3205200332C2777953023 @default.
- W3205200332 hasConceptScore W3205200332C2778198053 @default.
- W3205200332 hasConceptScore W3205200332C2778797674 @default.
- W3205200332 hasConceptScore W3205200332C2778938600 @default.
- W3205200332 hasConceptScore W3205200332C2780559512 @default.
- W3205200332 hasConceptScore W3205200332C2780875844 @default.
- W3205200332 hasConceptScore W3205200332C71924100 @default.
- W3205200332 hasConceptScore W3205200332C84393581 @default.
- W3205200332 hasIssue "Supplement_1" @default.
- W3205200332 hasLocation W32052003321 @default.
- W3205200332 hasOpenAccess W3205200332 @default.
- W3205200332 hasPrimaryLocation W32052003321 @default.
- W3205200332 hasRelatedWork W2125804349 @default.
- W3205200332 hasRelatedWork W2153348972 @default.
- W3205200332 hasRelatedWork W2363366439 @default.
- W3205200332 hasRelatedWork W2370173382 @default.
- W3205200332 hasRelatedWork W2593111446 @default.
- W3205200332 hasRelatedWork W2600441050 @default.
- W3205200332 hasRelatedWork W2735815044 @default.
- W3205200332 hasRelatedWork W2896102150 @default.
- W3205200332 hasRelatedWork W3096670476 @default.
- W3205200332 hasRelatedWork W3205200332 @default.
- W3205200332 hasVolume "42" @default.
- W3205200332 isParatext "false" @default.
- W3205200332 isRetracted "false" @default.
- W3205200332 magId "3205200332" @default.
- W3205200332 workType "article" @default.